Federation Des Caisses Desjardins Du Quebec Red Hill Biopharma Ltd. Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 14, 2024	SELL	$0.14 - $5.6 $22,290 - $891,615	-159,217 Closed	0 $0
Q4 2022 Aug 14, 2024	SELL	$0.14 - $695.9 $358 - $1.78 Million	-2,564 Reduced 1.58%	159,217 $22.3 Million
Q3 2022 Aug 14, 2024	BUY	$0.5 - $523.8 $33,952 - $35.6 Million	67,905 Added 72.33%	161,781 $81.4 Million
Q2 2022 Aug 14, 2024	BUY	$0.63 - $2.58 $21,668 - $88,739	34,395 Added 57.83%	93,876 $81.7 Million
Q1 2022 Aug 14, 2024	BUY	$1.65 - $3.12 $98,143 - $185,580	59,481 New	59,481 $150 Million
Q4 2021 Aug 30, 2024	BUY	$2.31 - $5.85 $129,782 - $328,670	56,183 New	56,183 $145 Million
Q3 2020 Aug 30, 2024	SELL	$6.34 - $10.83 $22,411 - $38,284	-3,535 Closed	0 $0
Q2 2020 Aug 30, 2024	SELL	$4.6 - $8.6 $16,928 - $31,648	-3,680 Reduced 51.0%	3,535 $23.7 Million
Q4 2019 Aug 30, 2024	SELL	$5.76 - $7.35 $6,624 - $8,452	-1,150 Reduced 13.75%	7,215 $43.8 Million
Q3 2019 Aug 30, 2024	SELL	$6.46 - $8.37 $39,018 - $50,554	-6,040 Reduced 41.93%	8,365 $58.9 Million
Q1 2019 Aug 30, 2024	SELL	$6.06 - $9.0 $151,893 - $225,585	-25,065 Reduced 63.5%	14,405 $120 Million
Q4 2018 Aug 30, 2024	BUY	$5.18 - $9.35 $204,454 - $369,044	39,470 New	39,470 $219 Million
Q3 2018 Aug 30, 2024	BUY	$6.0 - $11.35 $244,950 - $463,363	40,825 Added 710.0%	46,575 $411 Million
Q2 2018 Aug 30, 2024	SELL	$4.82 - $8.53 $64,997 - $115,027	-13,485 Reduced 70.11%	5,750 $49 Million
Q1 2018 Aug 30, 2024	BUY	$4.96 - $6.84 $39,308 - $54,207	7,925 Added 70.07%	19,235 $99.1 Million
Q4 2017 Aug 30, 2024	BUY	$4.58 - $10.81 $48,181 - $113,721	10,520 Added 1331.65%	11,310 $58.1 Million
Q1 2017 Aug 30, 2024	BUY	N/A	790	790 $7.58 Million

Others Institutions Holding RDHL

# of Institutions

Shares Held

40.4K

Call Options Held

Put Options Held

Eaton Vance Management Boston, MA

40.4K
Shares

$294,639
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About RedHill Biopharma Ltd.

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

More about RDHL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account